Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-135930
Filing Date
2024-12-12
Accepted
2024-12-12 18:00:03
Documents
1
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3480
  Complete submission text file 0000950170-24-135930.txt   4919
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address
BERGER FRANKLIN M (Reporting) CIK: 0001273885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39661 | Film No.: 241546210

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)